Francesca Domenech Wuttke, Ph.D. is the Chief Digital Officer of Almirall where sheis developing and executing an end-to-end companywide digital transformation. Sheis responsible for finding use cases across R&D, commercial, manufacturing,finance, legal and HR to apply digital solutions and services to bring efficiencies interms of time and cost and to open up new business channels for Almirall. Dr.Wuttke brings with her broad drug development and healthcare expertise in both theUS and Europe, with over 20 years of clinical, commercial, strategic andtransactional experience. She has worked with diverse organizations including start-ups, consulting, large and specialty pharma as well as academia. Most recently, sheled European investments as Managing Director for the MSD Global HealthInnovation Fund, LLC. Previously Dr. Wuttke led Almirall´s Corporate DevelopmentStrategy team to transact on both med device and pharma M&A opportunities with anew and targeted focus for the company. Before that Dr. Wuttke worked at Novartiswhere she was responsible for two Cell and Gene therapy opportunities that weresuccessfully brought into the organization as well as managing the strategy andcommercialization for the existing portfolio of cell therapy assets. Dr. Wuttke holds aPh.D. in Pharmacology from Weill Cornell Graduate School of Medical Sciences anda BA from Cornell University College of Arts and Sciences.
Almirall / Chief Digital Officer